HOME >> BIOLOGY >> NEWS
Jefferson scientists use gene therapy to restore function of damaged heart cells in lab

Researchers at Jefferson Medical College and Duke University have used gene therapy to help damaged heart cells regain strength and beat normally again in the laboratory. The work takes the scientists one step closer to eventual clinical trials in humans.

Walter Koch, Ph.D., director of the Center for Translational Medicine of the Department of Medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia, and his colleagues at Duke used a virus to carry a gene into the heart cells of individuals who had suffered from congestive heart failure. The gene introduced into these heart cells blocks the activity of an enzyme that is increased in failing human hearts and which contributes to the loss of the heart's contractile strength during the development of heart failure. When the activity of this enzyme is blocked by the gene therapy, the heart cells were able to contract at normal strength and their overall performance was improved.

Dr. Koch and his co-workers at Duke University Medical Center in Durham, N.C., report their findings April 6, 2004, in Circulation, a journal of the American Heart Association.

According to Dr. Koch, who is W.W. Smith Professor of Medicine at Jefferson Medical College of Thomas Jefferson University, researchers have known for some time that the beta-adrenergic receptor system fails to work properly in individuals with congestive heart failure. Such receptors "drive the heart both by rate and force of contraction," he says.

The researchers' target has been the beta-adrenergic kinase (ARK1), an enzyme that is elevated in human heart failure. One of its functions is to turn off beta-adrenergic receptors. "In heart failure, beta adrenergic receptor density is decreased, ARK is increased and both together cause dysfunctional beta receptor signaling," Dr. Koch says. "A failing heart then has little capacity to respond to exercise or stress because there are fewer receptors and the remaining rec
'"/>


5-Apr-2004


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
5. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
6. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
7. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
8. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
9. Jefferson scientists use gene repair technique to change albino mice hairs to black
10. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory
11. Jefferson scientists propose mechanism to control the bodys red blood cell and platelet production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... ... November 13, 2019 , ... NDA Partners Chairman ... a regulatory affairs and program management executive with more than 33 years of ... joined the firm as an Expert Consultant. , Robert Peterson has extensive ...
(Date:11/14/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... clinical trial for stem cell treatment of knee osteoarthritis . The first treatment came ... of VetStem Biopharma. , In July of 2019, PSC received FDA approval ...
(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... manufacturing of orthopedic medical devices, today announced the creation of a Global Regulatory ... in the Medical Device industry is that the regulatory element to any Medtech ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... November 12, 2019 , ... ... they have been selected by Lantern Pharma to provided preclinical screening and drug ... millions of data points using panels of unique and genetically edited cell lines ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... biopharmaceutical R&D, today announced that Immatics Biotechnologies , a clinical-stage biopharmaceutical ... to streamline their R&D operations related to the discovery and development ...
(Date:11/12/2019)... FALLS, Wis. (PRWEB) , ... November 12, 2019 ... ... label food ingredient solutions for the food and beverage industry launched a new ... to improve the digital experience. Now, the website offers global visitors updated ingredient ...
(Date:11/12/2019)... ... November 12, 2019 , ... Bode ... Director of Forensic Genealogy, Melinde Lutz Byrne, to the organization. Byrne’s team will ... provide investigative leads to law enforcement through proven genealogy and DNA analysis methods. ...
Breaking Biology Technology:
Cached News: